No Data
By-health Co., Ltd. (300146.SZ): It is estimated that the net income in 2024 will decrease by 55.33% to 68.51% year-on-year.
Glory Exchange on January 24 reports that By-health Co., Ltd. (300146.SZ) announced an expected net income of 550 million yuan to -780 million yuan for 2024, a decrease of 55.33% to 68.51% compared to the same period last year. The non-recurring net income is expected to be between 500 million yuan and -750 million yuan, a decline of 53.04% to 68.69% compared to the same period last year. 1. In 2024, the company will adhere to a strong Technology and strong brand Global Strategy, continuously promoting the implementation of "scientific nutrition" and more professional product innovation strategies centered on Consumer health value. During the reporting period, the consumption environment continued to change, and industry competition intensified.
Tomson Beijian: 2024 Annual Results Forecast
Byhealth Co., Ltd's (SZSE:300146) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
The ten worst-performing consumer leaders of 2024.
Survival is the fundamental principle.
The review results of the 2024 By-health Co., Ltd. Scientific Nutrition Research Fund have been announced, and 6 projects have received funding.
Guangzhou, December 27, 2024 /PR Newswire/ -- On December 27, By-health Co., Ltd. announced the list of funding projects for the 2024 Scientific Nutrition Research Fund. After evaluation, a total of 6 projects will receive funding from the Fund, covering research directions such as nutrition and anti-aging, new material research and development, dried blood spot metabolomics detection technology, and the screening of natural functional ingredients. The Scientific Nutrition Research Fund is the successor to the By-health Research Fund, established in 2012, aimed at gathering scientific research strength and promoting fundamental and applied research centered on dietary nutritional supplements. To make the fund more inclusive and diverse.
The Past Three Years for Byhealth (SZSE:300146) Investors Has Not Been Profitable
Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price
